XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

-1.9%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (10653)	7/7/1999 7:46:00 PM
From: Arthur Radley	Read Replies (1) of 17367

As it relates to the XOMA data released today, this is what concerns me about the Biogen data... " At 2-weeks post-treatment, 20% of Amevive patients had complete clearance vs 0% of placebo patients" The XOMA release doesn't mention "complete clearance". Am I reading too much into this?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next